Table 1.

Patients’ demographic and clinical characteristics.

PatientAge at Diagnosis, yrsSexANCA TypeDiseaseOrgans InvolvedBVAS/WG ScoreTime to Remission, moPeak Serum Creatinine, mg/dlSerum Creatinine During Sustained Remission, mg/dl
150Fp-ANCAMPAPN, K43.51.11.1
259Mc-ANCAGPAEA, K, L, J742.31.6
367Mp-ANCAMPAK, J633.61.9
449Mp-ANCAMPAK661.91.7
578Mp-ANCAMPAK, J632.82.6
663Mp-ANCAMPAS, K481.21.2
776Fp-ANCAMPAEA, K, J111.01.0
834MNegativeMPAK, L7613.21.2
923Fp-ANCAMPAK, L1161.51.0
  • p-ANCA: perinuclear antineutrophil cytoplasmic antibody; c-ANCA: cytoplasmic antineutrophil cytoplasmic antibody; GPA: granulomatosis with polyangiitis; MPA: microscopic polyangiitis; PN: peripheral nerve; K: kidney; EA: ear; L: lung; J: joint; S: skin; BVAS/WG: Birmingham Vasculitis Activity Score/Wegener’s granulomatosis.